NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NIAID E-123-2007-0-US-33 Monoclonal Antibodies That Neutralize Anthrax Toxin US DIV 14/595,475 9580492 Abandoned PDF
NCI E-227-2014-0-PCT-02 COMBINATION PRODUCT FOR THE PREVENTION OF SEXUALLY TRANSMITTED INFECTIONS PCT PCT PCT/US2015/011197 Expired
NCI E-227-2014-0-CN-05 Combination Of Griffithsin With Other Substances To Make A Product For The Prevention Of STD CN National Stage 201580006151.0 Abandoned
NCI E-227-2014-0-ZA-09 Combination Of Griffithsin With Other Substances To Make A Product For The Prevention Of STD ZA National Stage 2016/04687 Pending
NCI E-227-2014-0-IN-06 COMBINATION PRODUCT FOR THE PREVENTION OF SEXUALLY TRANSMITTED INFECTIONS IN National Stage 201617025677 Pending
NCI E-227-2014-0-BR-04 Combination Of Griffithsin With Other Substances To Make A Product For The Prevention Of STD BR National Stage BR1120160173112 Pending
NIAAA E-210-2012-0-US-03 Intralipid As A Contrast Agent To Enhance Subsurface Blood Flow Imaging US National Stage 14/414,183 10531803 Issued PDF
NIAID E-120-2001-0-BE-92 Development of Mutations Useful For Attenuating Dengue Viruses And Chimeric Dengue Viruses BE EP 15150784.5 Expired
NIAID E-120-2001-0-IE-97 Development of Mutations Useful For Attenuating Dengue Viruses And Chimeric Dengue Viruses IE EP 15150784.5 Expired
NIAID E-120-2001-0-IT-98 Development of Mutations Useful For Attenuating Dengue Viruses And Chimeric Dengue Viruses IT EP 15150784.5 Expired
NIAID E-120-2001-0-DE-94 Development of Mutations Useful For Attenuating Dengue Viruses And Chimeric Dengue Viruses DE EP 15150784.5 Expired
NIAID E-120-2001-0-FR-95 Development of Mutations Useful For Attenuating Dengue Viruses And Chimeric Dengue Viruses FR EP 15150784.5 Expired
NIAID E-120-2001-0-CH-93 Development of Mutations Useful For Attenuating Dengue Viruses And Chimeric Dengue Viruses CH EP 15150784.5 Expired
NIAID E-120-2001-0-GB-96 Development of Mutations Useful For Attenuating Dengue Viruses And Chimeric Dengue Viruses GB EP 15150784.5 Expired
NIAID E-085-2016-0-US-01 Composition And Methods For Generating And Immune Response To Filovirus US 62/102,425 Abandoned
NCI E-295-2012-0-AU-03 Anti-Viral Cnidarins AU National Stage 2015204680 Issued
NCI E-295-2012-0-EP-05 Anti-Viral Cnidarins EP National Stage 15701450.7 Issued
NCI E-141-2008-0-NZ-28 Complexes Of IL-15 And IL-15R AIpha And Uses Thereof NZ DIV 703668 Issued
NCI E-295-2012-0-PCT-02 Anti-Viral Cnidarins PCT PCT PCT/US2015/010797 Expired
NCI E-179-2008-0-US-03 Apelin Peptides, Antibodies Thereto, And Methods Of Use US DIV 14/593,099 Abandoned
NCI E-295-2012-0-CA-04 Anti-Viral Cnidarins CA National Stage 2935123 Pending
NHLBI E-758-2013-1-GB-09 Antibody Targeting Cell Surface Deposited Complement Protein C3d And Use Thereof GB EP 15701442.4 Issued
NHLBI E-758-2013-1-CH-06 Antibody Targeting Cell Surface Deposited Complement Protein C3d And Use Thereof CH EP 15701442.4 Issued
NHLBI E-758-2013-1-DE-07 Antibody Targeting Cell Surface Deposited Complement Protein C3d And Use Thereof DE EP 15701442.4 Issued
NHLBI E-758-2013-1-FR-08 Antibody Targeting Cell Surface Deposited Complement Protein C3d And Use Thereof FR EP 15701442.4 Issued
NHLBI E-758-2013-1-EP-04 Antibody Targeting Cell Surface Deposited Complement Protein C3d And Use Thereof EP National Stage 15701442.4 Issued
NCI E-062-2014-0-PCT-02 RAS Pathways As Markers Of Protection Against HIV And Means To Improve Vaccine Efficacy PCT PCT PCT/US2015/010664 Expired
NHLBI E-758-2013-1-PCT-01 Antibody Targeting Cell Surface Deposited Complement Protein C3d And Use Thereof PCT PCT COMB PCT/US2015/010620 Expired
NCI E-275-2014-0-US-01 FUROQUINOLINEDIONES AS INHIBITORS OF TDP2 US 62/100,968 Abandoned
NCATS E-203-2012-0-EP-05 METHODS AND COMPOSITIONS FOR THE INHIBITION OF PIN1 EP National Stage 13800857.8 Abandoned
NCATS E-203-2012-0-FR-10 METHODS AND COMPOSITIONS FOR THE INHIBITION OF PIN1 FR EP 13800857.8 Abandoned
NCATS E-203-2012-0-DE-09 METHODS AND COMPOSITIONS FOR THE INHIBITION OF PIN1 DE EP 13800857.8 Abandoned
NCATS E-203-2012-0-GB-11 METHODS AND COMPOSITIONS FOR THE INHIBITION OF PIN1 GB EP 13800857.8 Abandoned
NCI E-278-2014-0-US-01 Treatment Methods Using Peptide-Based Inhibitors of the Stat3-IL10 Pathway US 62/100,763 Abandoned
NIDA E-043-2015-0-US-01 Systems and Methods for Training and Imaging an Animal in an Awaken State US ORD 14/589,725 9717946 Issued PDF
NHLBI E-254-2003-3-US-21 Use of Nitrite Salts For The Treatment Of Cardiovascular Conditions US CON 14/589,324 9700578 Expired PDF
NIAID E-043-2014-2-PCT-01 NEUTRALIZING ANTIBODIES TO HIV-1 ENV AND THEIR USE PCT PCT PCT/US2015/010180 Expired
NCI E-132-2010-0-US-04 Methods Of Diagnosing And Prognosing Colonic Polyps US CON 14/589,238 Abandoned
NCI E-053-2015-0-US-01 Myc G-quadruplex Stabilizing Small Molecules And Their Use US 62/099,938 Abandoned
NIAID E-060-2015-0-US-01 NOVEL, MULTIVALENT, NANOPARTICLE-BASED VACCINES FOR INFLUENZA VIRUS US 62/098,755 Abandoned
NCI E-136-2012-0-KR-05 High-Affinity Monoclonal Antibodies To Glypican-3 And Use Thereof KR National Stage 10-2014-7037046 Issued
NCATS E-244-2014-0-US-01 Small Molecule Inhibitors Of Lactate Dehydrogenase and Methods of Use Thereof US 62/097,226 Abandoned
NIAID E-260-2014-0-US-01 Structure-based Design Of A Fusion Glycoprotein Vaccine For Metapneumovirus US 62/096,744 Abandoned
NICHD E-039-2015-0-US-01 Adeno-Associated Virus Vectors Encoding Modified G6PC For The Treatment of Glycogen Storage Disease US 62/096,400 Abandoned
NCI E-146-2007-1-US-02 Selenocysteine Mediated Hybrid Antibody Molecules US CON 14/579,180 Abandoned
NCATS E-243-2014-0-US-01 Mutant IDH1 Inhibitors Useful for Treating Cancer US 62/095,322 Abandoned
NEI E-089-2011-0-GB-01 Calcineurin Inhibitor-antibody Conjugates For The Treatment Of Th17 Driven Inflammatory Diseases. GB EP 14819058.0 Issued
NEI E-089-2011-0-EP-03 Calcineurin Inhibitor-antibody Conjugates For The Treatment Of Th17 Driven Inflammatory Diseases. EP National Stage 14819058.0 Issued
NEI E-089-2011-0-FR-01 Calcineurin Inhibitor-antibody Conjugates For The Treatment Of Th17 Driven Inflammatory Diseases. FR EP 14819058.0 Issued
NEI E-089-2011-0-DE-01 Calcineurin Inhibitor-antibody Conjugates For The Treatment Of Th17 Driven Inflammatory Diseases. DE EP 14819058.0 Issued